- Home
- IPG vs ASND Comparison
IPG vs ASND Comparison
Compare IPG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPG
- ASND
- Stock Information
- Founded
- IPG 1902
- ASND 2006
- Country
- IPG United States
- ASND Denmark
- Employees
- IPG N/A
- ASND N/A
- Industry
- IPG Advertising
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- IPG Consumer Discretionary
- ASND Health Care
- Exchange
- IPG Nasdaq
- ASND Nasdaq
- Market Cap
- IPG 8.9B
- ASND 10.6B
- IPO Year
- IPG N/A
- ASND 2015
- Fundamental
- Price
- IPG $24.43
- ASND $170.86
- Analyst Decision
- IPG Buy
- ASND Strong Buy
- Analyst Count
- IPG 9
- ASND 16
- Target Price
- IPG $32.50
- ASND $218.19
- AVG Volume (30 Days)
- IPG 9.2M
- ASND 435.4K
- Earning Date
- IPG 07-23-2025
- ASND 05-01-2025
- Dividend Yield
- IPG 5.44%
- ASND N/A
- EPS Growth
- IPG N/A
- ASND N/A
- EPS
- IPG 1.31
- ASND N/A
- Revenue
- IPG $9,001,000,000.00
- ASND $398,509,511.00
- Revenue This Year
- IPG N/A
- ASND $75.05
- Revenue Next Year
- IPG $2.74
- ASND $78.14
- P/E Ratio
- IPG $18.45
- ASND N/A
- Revenue Growth
- IPG N/A
- ASND 12.06
- 52 Week Low
- IPG $22.51
- ASND $111.09
- 52 Week High
- IPG $33.05
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- IPG 54.93
- ASND 52.37
- Support Level
- IPG $23.96
- ASND $166.84
- Resistance Level
- IPG $24.74
- ASND $180.78
- Average True Range (ATR)
- IPG 0.55
- ASND 5.57
- MACD
- IPG 0.18
- ASND -0.53
- Stochastic Oscillator
- IPG 84.00
- ASND 38.59
About IPG Interpublic Group of Companies Inc. (The)
Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe. IPG agreed to merge with Omnicom in December 2024, pending regulatory approval.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.